Introduction {#Sec1}
============

Lack of selenium in ruminants predispose to the white muscle disease (myopathy). In the course of this damage, calcium salts may be deposited among the muscle fibers in certain parts of the bodies of the affected animals. Likewise, inadequate intake of selenium in animals is related to some clinic manifestations like alterations in reproduction, reduction in resistance to diseases, perinatal mortality, retarded growth and wool production decrease (Underwood and Suttle [@CR13]).

Selenium consumed in foods and supplements exists in a number of organic and inorganic forms including selenomethionine (plant and animal sources and supplements), selenocysteine (mainly animal sources), selenate and selenite (mainly supplements) (Rayman [@CR8]). But, selenium deficiency can be prevented by different sources; sodium selenite is a current source using in livestock production.

Efficiency of absorption of selenium differs greatly between ruminants and nonruminants. In ruminants, microbial digestion in the rumen and reticulum precedes digestion in the abomasum and small intestine (NRC [@CR5]). Absorption of selenium is much lower in ruminants than in nonruminants. Absorption of orally administered Se was only 34% in sheep compared with 85% in swine (Mahan et al. [@CR4]). Low absorption of selenium in ruminants is believed to result from reduction of dietary selenium to insoluble forms such as elemental selenium or selenides in the rumen environment (Spears [@CR11]). Selenium in ruminant diets is not solely for the animal per se but also for rumen bacteria capable of metabolizing part of it (Serra et al. [@CR10]; Whanger and Weswing [@CR14]). Most of the Se in the ruminal fluids of sheep under supplementation is insoluble, indicating the influence of rumen environment on selenium bioavailability (Serra et al. [@CR10]; Jannes et al. [@CR2]).

In order to avoid this negative side effects polymer nanoparticulate systems are proposed. Up to now, sodium selenite has not been associated with nanoparticles. Consequently, the potentiality of these systems to improve the availability of this microelement was not yet evaluated. The use of Eudragit® RL and Eudragit® RS has been documented for the oral evaluation in rabbits of cyclosporine loaded nanoparticles (Ubrich et al. [@CR12]). Design of sodium selenite nanoparticles for oral administration in ruminants, has not been reported previously. The design and evaluation of controlled release nanoparticles consist in the entrapment of sodium selenite with different methods, solvents and polymer proportions, and further evaluation of the drug entrapment, particle morphology, particle size, z potential and polidispersity index.

Material and methods {#Sec2}
====================

Materials {#Sec3}
---------

Sodium selenite was purchased from J.T. Baker®, Eudragit® RL and RS were obtained from Helm, Mexico, Pluronic® F68 was from BASF, Germany, Ethanol and Acetone were purchased from J.T. Baker. All other chemicals used were of reagent grade.

Preparation of sodium selenite nanoparticles {#Sec4}
--------------------------------------------

Nanoparticles were prepared according to procedures of the, emulsion--evaporation and nanoprecipitation methods.

Emulsification--evaporation {#Sec5}
---------------------------

For this method 200 mg of Eudragit® RL and RS in different proportions (30:70 or 40:60 respectively) were dissolved in 16 mL of an organic solvent (ethanol or acetone) to obtain the organic solution. 20 mg of sodium selenite were dissolved in 52 mL of an aqueous solution of Pluronic F68 (0.5%, w/w). Organic solution was added to the aqueous solution and stirred magnetically during 3 min, and then, stirred with ultraturrax for 3 min (9500 rpm). Finally, solvent was evaporated by heating the solution (70°C) during 30 min and stirring magnetically.

Nanoprecipitation {#Sec6}
-----------------

The organic phase was prepared by dissolving 1000 mg of Eudragit RL and RL (400 mg and 600 mg respectively) in 10 mL of ethanol by sonication (Transsonic 570/H, ELMA) during 15 min. The organic solution was added into the aqueous phase (20 mL) containing Pluronic F68 (0.5%, w/w) and stirred magnetically.

Selenium encapsulation efficiency {#Sec7}
---------------------------------

The amount of selenium entrapped within the polymeric nanoparticle systems was determined by atomic absorption spectroscopy (AAS). Nanoparticles were recovered by centrifugation at 27,000 rpm/60 min (Beckman-Coulter, Optima L-100 XP). The formed pellets were recovered in 10 mL of deionized water. Supernatant as well as recovered nanoparticles were digested in nitric acid before injection into the AAS system (SpectrAA, Varian). The encapsulation was referred as the ratio between the selenium found in the nanoparticles and the theoretical quantity of selenium added expressed in percentage.

Particle size, z potential and PDI {#Sec8}
----------------------------------

Nanoparticle mean size, polydispersity index, and z potential were measured using a Zetasizer Nano ZS (Malvern Instruments Ltd., Worcestershire, UK). The mean size and polydispersity of nanoparticles were assessed by photon correlation spectroscopy The PDI values range from 0 to 1; a higher value indicates a less homogeneous NP size distribution. The results were all normalized with respect to a polystyrene standard suspension.

Scanning electron microscopy (SEM) {#Sec9}
----------------------------------

### Nanoparticles prepared by emulsion--evaporation {#Sec10}

Morphological examination of nanoparticles was performed using a scanning electron microscope (JEOL JSM-35C, Jeol Ltd., Japan). 10 μL of nanoparticles were dispersed in 1 ml of deionized water, then drops of the dispersion (20 μL) were air-dried over metallic studs, and coated with gold using a gold sputter module in a high vacuum evaporator (Ion Sputter JFC-III00).

### Nanoparticles prepared by nanoprecipitation {#Sec11}

After nanoparticle production, nanoparticles were divided into two parts. The first was immediately diluted with distilled water to obtain a dilution 1:100. The second one was centrifuged (27, 000 rpm/60 min) and then, the formed pellet was recovered in 10 mL of deionized water. 10 μL of each nanoparticle solutions were dispersed in 1 ml of deionized water, and then drops of the dispersions (20 μL) were air-dried over metallic studs, and coated with gold using a gold sputter module in a high vacuum evaporator (Ion Sputter JFC-III00). Samples were then observed using a scanning electron microscope (JEOL JSM-6390 Jeol Ltd., Japan).

### In vitro selenium release {#Sec12}

In vitro release of selenium from nanoparticles was evaluated in phosphate buffers (pH 2, 3 and 4) and deionized water (pH 6). Buffers were prepared according to procedures proposed by Mexican Pharmacopeia (9). Nanoparticle colloids were put into a dialysis membrane (Spectra/Por® 3500 MWCO) and sealed with dialysis membrane closures (Spectra/Por®), then, the system was put in a flask filled with 900 mL of deionized water and stirred magnetically during 30 min in order to eliminate non encapsulated selenium. Dialysis systems containing 5 mL of purified nanoparticles were prepared and placed in flasks containing 200 mL of buffer solutions or deionized water, stirred magnetically and maintained at 37°C. At appropriate intervals (0, 15, 30, 45, 60, 75, 90, 105 and 120 min), 20 mL of the sample were taken and replaced by 20 mL of each fresh dissolution fluid to maintain a constant volume. The samples were then analyzed by Atomic Absorption Spectrophotometry. The mean of three determinations was used to calculate the drug release from each of the systems.

### Statistical analyses {#Sec13}

Statistical analyses for particle size, z potential, PDI and selenium release were carried out with the software package SAS V8 using the GLM procedure (SAS [@CR9]). Means were obtained with the Mean instruction and a multiple comparison among means was done with a Tukey's test. Interaction among solvents and polymer proportions were also evaluated. Means comparison among methods, solvents and polymer proportions was carried out with a Student's t-test. In all cases a value of P \< 0.05 was considered to be statistically significant.

Results and discussion {#Sec14}
======================

Considering that an important aspect in the preparation of nanoparticles, from both fundamental and technological viewpoints, is the production of a desired particle size with a narrow size distribution and a good stability (Galindo et al. [@CR1]), all methods were compared by analyzing the physicochemical variables that could affect these nanoparticle characteristics.

The mean particle size, z potential and PDI of different nanometric systems are presented in Table [1](#Tab1){ref-type="table"}. All nanometric systems presented significant differences for the evaluated variables (P \< 0.05). The system N. P. Ethanol 40:60 showed the major values for all variables, it presented a mean particle size of 213.8 nm and a z potential value of 31.8 mV. Recommend values of z potential for colloid suspension must have values superior to ± 30 mV (12). The magnitude of the zeta potential gives an indication of the potential stability of the colloidal system. If all the particles in suspension have a large negative or positive zeta potential then they will tend to repel each other and there will be no tendency for the particles to come together. However, if the particles have low zeta potential values then there will be no force to prevent the particles coming together and flocculating. The highest PDI indicates that nanoparticles generated by this system had the lowest homogeneity in size distribution. Table 1Particle size, z potential and PDI of different nanometric systems (mean ± S.D.)SystemParticle size (nm)Z potential Z (mV)PDIE. E. Acetone 30:7044.8 ± 0.55 b26.7 ± 1.1 b0.379 ± 0.004 bE. E. Acetone 40:6042.6 ± 0.22 c25.9 ± 2.4 cb0.374 ± 0.014 bE. E. Ethanol 30:7034.6 ± 0.05 e19.1 ± 1.0 d0.233 ± 0.004 dE. E. Ethanol 40:6038.9 ± 0.61 d22.6 ± 1.0 cd0.343 ± 0.003 cN. P. Ethanol 40:60213.8 ± 1.38 a31.8 ± 0.7 a0.494 ± 0.005 aMeans with different letters within a column are significantly different (P \< 0.05)E.E. = Emulsion--EvaporationN.P. = Nanoprecipitation30:70 = 30% Eudragit RL and 70% de Eudragit RS40:60 = 40% Eudragit RL and 60% de Eudragit RS

The lowest values for evaluated variables were obtained in E. E. Ethanol 30:70 system, it showed a mean particle size of 34.6 nm and a PDI of 0.233 that is directly related to the best particle size distribution of all evaluated systems, however, this system is not stable according to the minimum recommended value of z potential proposed by Malvern Instruments (30 mV).

All results differed significantly (P \< 0.05) between the two production methods (Table [2](#Tab2){ref-type="table"}). Nanoparticles produced by nanoprecipitation were 431% bigger than nanopartiles produced by emulsion--evaporation. Z potential and PDI increased 34.9 and 48.7% when nanoprecipitation was used. Nanoprecipitation showed a z potential value superior to the minimum recommended for stable colloidal suspensions (30 mV), nevertheless, it showed a high value for PDI, which suggest that mean particle size presented a great variation. Table 2Particle size, z potential and PDI of nanoparticles prepared by different methods (mean ± S.D.)MethodParticle size (nm)Z potential Z (mV)PDIEmulsion--Evaporation40.2 ± 4.05 a23.6 ± 3.3 b0.332 ± 0.062 bNanoprecipitation213.8 ± 1.37 b31.8 ± 0.7 a0.494 ± 0.004 aMeans with different letters within a column are significantly different (P \< 0.05)

Nanoparticles produced by nanoprecipitation were spherical, while nanoparticles produced by emulsion--evaporation were spherical as well as irregular (Fig. [1](#Fig1){ref-type="fig"}). Even zetasizer showed a mean particle size for emulsion--evaporation method less than 45 nm, nanoparticles were not observed in SEM, probably due to nanoparticles were not purified before observation and excess of polymer could interfere in the characterization process (Raula et al. [@CR7]). In the other hand, nanoparticles produced by nanoprecipitation were successfully characterized. In this case excess of polymer was eliminated by centrifugation (27, 000 rpm/60 min) before characterization and did not interfere in SEM examination. Other works produced tracolimus nanoparticles using the polymer poly (lactic-co-glycolic acid) and the emulsion evaporation method. The encapsulation of tracolimus resulted in spherical particles with the diameter varying between 30 and 60 µm. Microparticles were successfully characterized, however, when microparticles were prepared under reduced pressure at room temperature, the evaporation of the inner aqueous phase resulted in a sponge-like structure. Lowering the temperature with an ice bath led to distinctly less porous particles with a relatively smooth surface (Lamprecht et al. [@CR3]). Fig. 1Scanning electron micrographs of microparticles and nanoparticles prepared by (**a**) emulsion--evaporation and (**b**) nanoprecipitation

Particle size, z potential and PDI differed significantly (P \< 0.05) when two different solvents were used in nanoparticle preparation (Table [3](#Tab3){ref-type="table"}). When ethanol was used nanoparticle size grater 18%, z potential 25% and PDI 30%. Even if use of ethanol guarantees a better stability of the system, it must be remembered that a higher value of PDI is related with a less homogeneous particle size distribution. Table 3Particle size, z potential and PDI of nanoparticles prepared with different solvents (mean ± S.D.)SolventParticle size (nm)Z potential Z (mV)PDIEthanol43.4 ± 1.23 a26.3 ± 1.7 a0.376 ± 0.009 aAcetone36.8 ± 2.39 b20.9 ± 2.1 b0.288 ± 0.060 bMeans with different letters within a column are significantly different (P \< 0.05)

The formation of spherical nanoparticles and their morphology can be influenced by proper experimental conditions. The solubility of the polymer in the solvent and the volatility of the solvent are probably the most important factors that influence on the particle formation. A concept of solvent quality for a polymer is noteworthy. As the solubility of the polymer increases, the solvent quality for the polymer improves, and vice versa. The solvent medium is, therefore, good or poor for the polymer, respectively. In a good solvent, polymer chains are expanded, whereas they shrink and eventually phase separates when the solvent quality worsens. In the good solvent, the polymer--solvent interactions dominate, whereas this is replaced by the interactions between polymer chains in the poor solvent (Raula et al. [@CR7]). Polymer Eudragit RL 100 y RS 100 in this work showed a better solubility in acetone, this difference in solubility of the polymers in solvents, may explain differences observed in evaluates variables.

None of the results did differ significantly (P \> 0.05) between the two polymer proportions (P \> 0.05, Table [4](#Tab4){ref-type="table"}), probably due to differences in polymeric proportions were not strongly marked. Further works must evaluate polymeric proportions strongly marked and Eudragit RL and RS polymers individually. Solvent proportion interaction was evaluated; all variables presented a significant interaction: mean particle size (P \< 0.0001), z potential (P \< 0.0396) and PDI (P \< 0.0001). Table 4Particle size, z potential and PDI of nanoparticles prepared with different polymers proportions (mean ± S.D.)ProportionParticle size (nm)Z potential Z (mV)PDI30:7039.7 ± 5.58 a22.9 ± 4.2 a0.306 ± 0.080 a40:6040.8 ± 2.07 a24.3 ± 2.4 a0.359 ± 0.019 aMeans with different letters within a column are significantly different (P \< 0.05)30:70 = 30% Eudragit RL y 70% de Eudragit RS40:60 = 40% Eudragit RL y 60% de Eudragit RS

Table [5](#Tab5){ref-type="table"} displays correlations between evaluated variables. Mean particle size is direct correlated to z potential (r^2^ = 0.912, P \< 0.01). Bigger nanoparticles are more stables, because higher z potential values are related to a more stables colloidal systems. Particle size also shows a good correlation with PDI (r^2^ = 0.930; P \< 0.01). Bigger particles are more variable in particle size distribution, due to high values of PDI correspond to a less homogeneous particle size. Z potential and PDI have a positive correlation (r^2^ = 0.881; P \< 0.01); when z potential and PDI increases, nanoparticles becomes more stables but homogeneity in particle size distribution decreases. It is necessary to have a balance between these variables in order to achieve stable particles with a good distribution of the particle size. Data also were analyzed for quadratic regression, obtaining this formula. $\documentclass[12pt]{minimal}
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Selenium release from nanoparticles in different pH and time are presented in Fig. [2](#Fig2){ref-type="fig"}. The maximum selenium release is obtained before minute 45 in all cases. Selenium release presented significantly differences (P \< 0.05) for different times in all pH values. Lower values than pH 4, increased the selenium release in 62% compared with pH 6. The results may have a positive impact on animal production. The rumen pH vary from 5.5 to 6.5, out of this values, animals may have problems of acidosis or alkalosis. Essentially, no absorption of selenium occurred in the rumen and abomasum, and the greatest absorption of selenium occurred in the small intestine and the cecum of sheep (NRC [@CR6]). Low absorption of selenium in ruminants is believed to result from reduction of dietary selenium to insoluble forms such as elemental selenium or selenides in the rumen environment. This selenium is not available for the animal (Spears [@CR11]). The abomasum and duodenum pH is less to 4; under this condition nanoparticles present the highest release. Nanoparticles may represent an advantage to increase bioavailability of the mineral, because, it dose a low concentration in pH 6, this benefit to rumen microorganisms which are capable of metabolizing part of it and the mayor release of selenium occurs in acid condition, this may represent a better availability of the mineral in the small intestine. This in vitro study shows positive results in order to evaluate sodium selenite nanoparticles in an in vivo study. Fig. 2Released selenium from sodium selenite nanoparticles (µg/mL) in different pH and times

Conclusion {#Sec15}
==========

This study shows that the encapsulation of sodium selenite in nanoparticles by the emulsion--evaporation and nanoprecipitation methods when using Eudragit RL and RS is feasible. Nanoprecipitation generated spherical nanoparticles with a great variation in particle size distribution while nanoparticles prepared by emulsion--evaporation presented spherical as well as amorphous nanoparticles, and a great homogeneity of particle size. Nanoparticles prepared by nanoprecipitation were more stables since z potential increased 34.9%. When ethanol was used, particle size increased 18% and particles were more stables but particle size distribution was less homogeneous. Different polymer proportions evaluated were not different. All evaluated variables showed a good correlation. A balance among evaluated variables must be achieved to produce nanoparticles with a desired particle size, stability and particle size distribution.
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